The CMDH Test has been developed by a cytologist and tested in clinical trials on more than 160,000 samples over a period of 8 years.

With the CMDH test,

• the cytologist retains control of the sample-taking technique but considerably increases the productivity of the laboratory,
• a technician can prepare 40 to 50 slides per hour, without it requiring complicated equipment.

The CMDH test does not require learning a new technique of microscopic analysis and interpretation.

Users of the CMDH test appreciate not only its low cost but also the quality of the smears, which is consistant and does not depend on who took the samples; other advantages include the stabilisation of the coloration and the length of time that the samples can be stored.

The quality of the slides achieved with the CMDH Test enable earlier detection of lesions, and thus a saving in test programmes based on longer cycles between two screenings.

The CMDH team sells its savoir-faire to laboratories and medical teams, including training and initial support, as well as compiling the statistics of detected lesions. It is also involved in the development of public health screening campaigns for the detection of cervical cancer using the CMDH Test.

A MULTI-PURPOSE preserving agent whatever the type of cytological sample !

Whatever the type of cytological sample, the same preserving agent is used, with the additional advantage that the size of the smear can be adapted to the cellular structure of the sample.

The CMDH procedure [shaking, calibration and centrifuging in liquid phase] is applicable to:

• cervico-vaginal cytology
• endometrial cytology
• urinary cytology
• the urinary system (urine, bladder, urethra and, ureter samples)
• broncho-pulmonary cytology
• cerebro-spinal fluid cytology
• sinovial fluid cytology
• organ cytology
• smears for in situ hybridisation